Drugs / Naive HBI0101 CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07333430 | Jan 2026 → Dec 2027 expected | plasma cell myeloma | Hadassah Medical Organization | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Naive HBI0101 CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07333430 ↗ |
| Modality | Cell therapy | “autologous T cells transduced ex-vivo” NCT07333430 ↗ |